NDC Code(s) : 69924-032-01, 69924-032-02, 69924-033-01, 69924-033-02, 69924-031-01, 69924-031-02
Packager : OUTIN FUTURES CORP.

Category : HUMAN PRESCRIPTION DRUG LABEL

DEA Schedule : none

Marketing Status : New Drug Application

INGREDIENTS AND APPEARANCE

OOZOO FACE IN-SHOT MASK ILLUMINATION AMPOULE 2GLYCERIN LIQUID
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:69924-032
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
GLYCERIN(UNII: PDC6A3C0OX)
(GLYCERIN - UNII:PDC6A3C0OX) 		GLYCERIN0.58 mg in 2.8 mL
Inactive Ingredients
Ingredient Name Strength
PHELLINUS LINTEUS WHOLE(UNII: YVO92B1UCA)
PHENOXYETHANOL(UNII: HIE492ZZ3T)
ETHYLHEXYLGLYCERIN(UNII: 147D247K3P)
1,2-HEXANEDIOL(UNII: TR046Y3K1G)
BUTYLENE GLYCOL(UNII: 3XUS85K0RA)
ADENOSINE(UNII: K72T3FS567)
WATER(UNII: 059QF0KO0R)
ALCOHOL(UNII: 3K9958V90M)
PROPANEDIOL(UNII: 5965N8W85T)
MYROTHAMNUS FLABELLIFOLIA LEAF(UNII: 6Y9E0R40J5)
ASCORBIC ACID(UNII: PQ6CK8PD0R)
CITRIC ACID MONOHYDRATE(UNII: 2968PHW8QP)
ECTOINE(UNII: 7GXZ3858RY)
EDETATE DISODIUM(UNII: 7FLD91C86K)
TROMETHAMINE(UNII: 023C2WHX2V)
CARBOXYPOLYMETHYLENE(UNII: 0A5MM307FC)
XANTHAN GUM(UNII: TTV12P4NEE)
HYDROXYETHYL CELLULOSE (100 MPA.S AT 2%)(UNII: R33S7TK2EP)
PEG-60 HYDROGENATED CASTOR OIL(UNII: 02NG325BQG)
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:69924-032-025 in 1 PACKAGE 06/09/2016
1NDC:69924-032-012.8 mL in 1 SYRINGE Type 1: Convenience Kit of Co-Package
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph final part347 09/06/2016
OOZOO FACE IN-SHOT MASK ILLUMINATION MASKGLYCERIN PATCH
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:69924-033
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
GLYCERIN(UNII: PDC6A3C0OX)
(GLYCERIN - UNII:PDC6A3C0OX) 		GLYCERIN5.56 mg in 27 mL
Inactive Ingredients
Ingredient Name Strength
PHELLINUS LINTEUS WHOLE(UNII: YVO92B1UCA)
PHENOXYETHANOL(UNII: HIE492ZZ3T)
ETHYLHEXYLGLYCERIN(UNII: 147D247K3P)
1,2-HEXANEDIOL(UNII: TR046Y3K1G)
DIPROPYLENE GLYCOL(UNII: E107L85C40)
OLIVE OIL(UNII: 6UYK2W1W1E)
CETEARYL OLIVATE(UNII: 58B69Q84JO)
SORBITAN OLIVATE(UNII: MDL271E3GR)
CARBOXYPOLYMETHYLENE(UNII: 0A5MM307FC)
TREHALOSE(UNII: B8WCK70T7I)
TROMETHAMINE(UNII: 023C2WHX2V)
BETAINE(UNII: 3SCV180C9W)
XANTHAN GUM(UNII: TTV12P4NEE)
ADENOSINE(UNII: K72T3FS567)
ROYAL JELLY(UNII: L497I37F0C)
OENOTHERA BIENNIS FLOWER(UNII: Y1YXJ1M6Z5)
WATER(UNII: 059QF0KO0R)
BUTYLENE GLYCOL(UNII: 3XUS85K0RA)
GREEN TEA LEAF(UNII: W2ZU1RY8B0)
CHRYSANTHELLUM INDICUM TOP(UNII: STJ856D1Z0)
RICE BRAN(UNII: R60QEP13IC)
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:69924-033-025 in 1 PACKAGE 06/09/2016
1NDC:69924-033-0127 mL in 1 PATCH Type 1: Convenience Kit of Co-Package
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph final part347 09/06/2016
OOZOO FACE IN-SHOT MASK ILLUMINATION AMPOULE 1GLYCERIN LIQUID
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:69924-031
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
GLYCERIN(UNII: PDC6A3C0OX)
(GLYCERIN - UNII:PDC6A3C0OX) 		GLYCERIN0.57 mg in 2.8 mL
Inactive Ingredients
Ingredient Name Strength
ALLANTOIN(UNII: 344S277G0Z)
PANTHENOL(UNII: WV9CM0O67Z)
TREHALOSE(UNII: B8WCK70T7I)
TROMETHAMINE(UNII: 023C2WHX2V)
GLYCERYL MONOSTEARATE(UNII: 230OU9XXE4)
PEG-100 STEARATE(UNII: YD01N1999R)
POLYSORBATE 20(UNII: 7T1F30V5YH)
PHENYL TRIMETHICONE(UNII: DR0K5NOJ4R)
CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED)(UNII: 59TL3WG5CO)
POLYISOBUTYLENE (1000 MW)(UNII: 5XB3A63Y52)
SILICON DIOXIDE(UNII: ETJ7Z6XBU4)
EDETATE DISODIUM(UNII: 7FLD91C86K)
PHELLINUS LINTEUS WHOLE(UNII: YVO92B1UCA)
1,2-HEXANEDIOL(UNII: TR046Y3K1G)
PHENOXYETHANOL(UNII: HIE492ZZ3T)
ETHYLHEXYLGLYCERIN(UNII: 147D247K3P)
DIPROPYLENE GLYCOL(UNII: E107L85C40)
CYCLOMETHICONE 5(UNII: 0THT5PCI0R)
CYCLOMETHICONE 6(UNII: XHK3U310BA)
HYALURONATE SODIUM(UNII: YSE9PPT4TH)
TITANIUM DIOXIDE(UNII: 15FIX9V2JP)
ALKYL (C12-15) BENZOATE(UNII: A9EJ3J61HQ)
POLYHYDROXYSTEARIC ACID (2300 MW)(UNII: YXH47AOU0F)
ALUMINUM OXIDE(UNII: LMI26O6933)
ALUMINUM STEARATE(UNII: U6XF9NP8HM)
CETEARYL ETHYLHEXANOATE(UNII: 9M64UO4C25)
ALUMINUM HYDROXIDE(UNII: 5QB0T2IUN0)
TRIETHOXYCAPRYLYLSILANE(UNII: LDC331P08E)
MEDIUM-CHAIN TRIGLYCERIDES(UNII: C9H2L21V7U)
MICA(UNII: V8A1AW0880)
ADENOSINE(UNII: K72T3FS567)
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:69924-031-025 in 1 PACKAGE 06/09/2016
1NDC:69924-031-012.8 mL in 1 SYRINGE Type 1: Convenience Kit of Co-Package
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph final part347 09/06/2016

PRINCIPAL DISPLAY PANEL

image description

PRINCIPAL DISPLAY PANEL

image description

PRINCIPAL DISPLAY PANEL

image description